Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.
For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
Home
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2022 to 31 August 2022 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2022 to 31 August 2022 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)
Publication metadata
- Published:
- Corporate author(s): Directorate-General for Health and Food Safety (European Commission) , European Commission
- Subject: drug surveillance , EU Member State , market approval , marketing standard , medicinal product , veterinary medicinal product , withdrawal from the market
- OJ : JOC_2022_376_R_0001
- CELEX : 52022XC0930(09)
- IMMC : PUB(2022)1108/2230789
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages